O Eber

1.7k total citations
93 papers, 1.2k citations indexed

About

O Eber is a scholar working on Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, O Eber has authored 93 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Endocrinology, Diabetes and Metabolism, 18 papers in Pulmonary and Respiratory Medicine and 12 papers in Physiology. Recurrent topics in O Eber's work include Thyroid Disorders and Treatments (34 papers), Thyroid Cancer Diagnosis and Treatment (12 papers) and Blood properties and coagulation (8 papers). O Eber is often cited by papers focused on Thyroid Disorders and Treatments (34 papers), Thyroid Cancer Diagnosis and Treatment (12 papers) and Blood properties and coagulation (8 papers). O Eber collaborates with scholars based in Austria, Germany and Netherlands. O Eber's co-authors include W Langsteger, P Költringer, Bernd Eber, Johann Auer, Peter Lind, F. Lembeck, P. Caron, Wilmar M. Wiersinga, Paolo Vitti and G. Benker and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, International Journal of Cancer and Life Sciences.

In The Last Decade

O Eber

84 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O Eber Austria 17 664 169 168 161 111 93 1.2k
J. L. Touber Netherlands 18 743 1.1× 356 2.1× 179 1.1× 52 0.3× 72 0.6× 31 1.1k
Carl V. Felton United Kingdom 14 716 1.1× 198 1.2× 155 0.9× 41 0.3× 157 1.4× 24 1.5k
Keith Drummond Canada 6 405 0.6× 113 0.7× 171 1.0× 110 0.7× 298 2.7× 6 1.2k
Thaddeus E. Prout United States 13 716 1.1× 250 1.5× 295 1.8× 68 0.4× 215 1.9× 32 1.3k
E. Vittinghus Denmark 15 427 0.6× 101 0.6× 146 0.9× 51 0.3× 281 2.5× 24 1.3k
Carlos R. Ayers United States 20 538 0.8× 325 1.9× 293 1.7× 120 0.7× 484 4.4× 46 1.4k
H Dige‐Petersen Denmark 19 318 0.5× 203 1.2× 83 0.5× 128 0.8× 357 3.2× 69 1.0k
JR Attali France 21 349 0.5× 290 1.7× 128 0.8× 214 1.3× 447 4.0× 48 1.2k
Edward J. Busick United States 5 791 1.2× 216 1.3× 111 0.7× 154 1.0× 387 3.5× 5 1.4k
Abraham Borkowski Belgium 14 264 0.4× 120 0.7× 174 1.0× 68 0.4× 130 1.2× 33 845

Countries citing papers authored by O Eber

Since Specialization
Citations

This map shows the geographic impact of O Eber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O Eber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O Eber more than expected).

Fields of papers citing papers by O Eber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O Eber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O Eber. The network helps show where O Eber may publish in the future.

Co-authorship network of co-authors of O Eber

This figure shows the co-authorship network connecting the top 25 collaborators of O Eber. A scholar is included among the top collaborators of O Eber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O Eber. O Eber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Auer, Johann, et al.. (2001). Subclinical hyperthyroidism as a risk factor for atrial fibrillation. American Heart Journal. 142(5). 838–842. 229 indexed citations
2.
Eber, O. (1998). [Development of preventive iodine administration in Austria].. PubMed. 110(21). 733–7. 6 indexed citations
3.
Delange, François, G. Benker, P. Caron, et al.. (1997). Thyroid volume and urinary iodine in European schoolchildren: standardization of values for assessment of iodine deficiency. European Journal of Endocrinology. 136(2). 180–187. 241 indexed citations
4.
Költringer, P, W Langsteger, & O Eber. (1995). Dose-dependent hemorheological effects and microcirculatory modifications following intravenous administration of Ginkgo biloba special extract EGb 761. 15(15). 649–656. 22 indexed citations
5.
Langsteger, Werner, et al.. (1994). Postpartum thyroiditis and familial dysalbuminemic hyperthyroxinemia.. The Journal of Clinical Endocrinology & Metabolism. 78(1). 58–62. 6 indexed citations
6.
Büchinger, W., et al.. (1993). [TBG isoforms in the course of hyperthyroidism].. PubMed. 20(1-2). 20–3.
7.
Langsteger, W, et al.. (1993). The impact of geographical, clinical, dietary and radiation-induced features in epidemiology of thyroid cancer. European Journal of Cancer. 29(11). 1547–1553. 35 indexed citations
8.
Költringer, P, et al.. (1993). [Hemorheologic effects of ginkgo biloba extract EGb 761. Dose-dependent effect of EGb 761 on microcirculation and viscoelasticity of blood].. PubMed. 111(10). 170–2. 17 indexed citations
9.
Köhn, H, et al.. (1993). 99mTc-DTPA aerosol for same-day post-perfusion ventilation imaging: Results of a multicentre study. European Journal of Nuclear Medicine and Molecular Imaging. 20(1). 4–9. 10 indexed citations
10.
Wilders‐Truschnig, M., Petra Mooij, O Eber, et al.. (1993). Expression of various MHC class II molecules and of intracellular adhesion molecule-1 (ICAM-1) on focal clusters of dendritic cells in iodine deficiency goitres. Clinical & Experimental Immunology. 92(3). 397–403. 4 indexed citations
11.
Reisecker, F., et al.. (1992). Hypervolemic haemodilution and completed stroke: how important is the application time for its effect?. Neurological Research. 14(2). 171–173. 5 indexed citations
12.
Büchinger, W., O Eber, Georg Uray, Peter Lind, & Wolfgang Lindner. (1991). Synthesis and effects on peripheral thyroid hormone conversion of (R)‐4‐hydroxypropranolol, a main metabolite of (R)‐propranolol. Chirality. 3(2). 145–150. 2 indexed citations
13.
Költringer, P, W Langsteger, P Lind, et al.. (1991). [Gallopamil and changes of adenosine diphosphate- and collagen-induced thrombocyte aggregation].. PubMed. 41(8). 786–8. 2 indexed citations
14.
Lind, Peter, et al.. (1990). Immunoscintigraphy of inflammatory processes with a technetium-99m-labeled monoclonal antigranulocyte antibody (MAb BW 250/183).. PubMed. 31(4). 417–23. 56 indexed citations
15.
Wilders‐Truschnig, M., Hemmo A. Drexhage, G. Leb, et al.. (1990). Chromatographically Purified Immunoglobulin G of Endemic and Sporadic Goiter Patients Stimulates FRTL5 Cell Growth in a Mitotic Arrest Assay*. The Journal of Clinical Endocrinology & Metabolism. 70(2). 444–452. 26 indexed citations
16.
Langsteger, W, P Költringer, Michal Mokrý, et al.. (1990). Transient Prealbumin- Associated Hyperthyroxinemia in TSH-Producing Pituitary Adenoma. Nuklearmedizin - NuclearMedicine. 29(1). 40–43. 3 indexed citations
17.
Költringer, P, et al.. (1989). [Microcirculation in parenteral Ginkgo biloba extract therapy].. PubMed. 101(6). 198–200. 14 indexed citations
18.
Költringer, P & O Eber. (1989). [Collagen-induced thrombocyte aggregation in parenteral therapy using Ginkgo biloba].. PubMed. 139(5). 92–4. 5 indexed citations
19.
Langsteger, W, P Lind, Bernd Eber, et al.. (1989). Diagnosis of hepatic hemangioma with 99mTc‐labeled red cells: single photon emission computed tomography (SPECT) versus planar imaging. Liver International. 9(5). 288–293. 2 indexed citations
20.
Lind, Peter & O Eber. (1986). [Treatment of inappropriate TSH secretion with Triac].. PubMed. 13(1). 13–6. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. L. Touber Breakdown of academic impact, for papers by Carl V. Felton Breakdown of academic impact, for papers by Keith Drummond Breakdown of academic impact, for papers by Thaddeus E. Prout Breakdown of academic impact, for papers by E. Vittinghus Breakdown of academic impact, for papers by Carlos R. Ayers Breakdown of academic impact, for papers by H Dige‐Petersen Breakdown of academic impact, for papers by JR Attali Breakdown of academic impact, for papers by Edward J. Busick Breakdown of academic impact, for papers by Abraham Borkowski
Rankless by CCL
2026